Ashwin Mittal, CMD and CEO, Course5 Intelligence Ltd. Mumbai, 01st February 2022 (GNI): India’s Hon. Union Finance Minister Smt. Nirmala Sitharaman’s futuristic growth friendly Union Budget rightly envisioned the roadmap for India entering Amrit Kaal,…
New Delhi, 31st January 2022 (GNI): Satin Creditcare Network Limited (SCNL) (NSE: SATIN, BSE: 539404) has announced its un-audited and limited reviewed financial results for the quarter and nine months ended 31st December 2021. The financial numbers…
Under its #SheMeansBusiness program Meta has partnered with FICCI’s Empowering the Greater 50% initiative to provide women led SMBs access to Meta’s digital tools, programs and resourcesHosts first National Women Entrepreneurship Summit to encourage industry…
Happiest Minds Technologies Limited (NSE:HAPPSTMNDS), a ‘Born Digital. Born Agile’, digital transformation and IT solutions company, announced its Q3FY22 results registering industry-leading revenue rise by 47.2% on y-o-y basis and EBITDA growth of 27.8% on a yearly comparison….
Mumbai, January 28, 2022 (GNI): Moglix has raised $250 Million in its latest Series F funding round, at a valuation of $2.6 Billion. This investment was led by Tiger Global and Alpha Wave Global with…
मुंबई, 27 जनवरी, 2022 (GNI): महिंद्रा लॉजिस्टिक्स लिमिटेड (एमएलएल), जो भारत के बड़े 3पीएल समाधान प्रदाताओं में से एक है, ने 31 दिसंबर, 2021 को समाप्त तिमाही के लिए अपने समेकित वित्तीय परिणामों की आज घोषणा की। Q3 FY21 की तुलना में Q3 FY22 का प्रदर्शन · राजस्व…
Mumbai, January 27, 2022 (GNI): BharatPe, India’s leading fintech company for merchants, today announced that it has ramped up the reach of its POS business (BharatSwipe) by 25X to 250+ cities in the last 12…
Srikant Kanhere CFO and Angshu Mallick MD of Adani Wilmar management · A discount of Rs. 21 per equity share is being offered to eligible employees bidding in the employee reservation portion · Floor price is 218 times…
– Demand growth in Tier-II cities remains ahead of Tier-I – Tier-II cities like Chandigarh and Lucknow witness high demand Mumbai, 18th January 2022 (GNI): Searches for CCTV cameras, installation, and repair services witnessed a major rise…
The phase 2, double-blind, randomised controlled COVAXIN® trial demonstrated long-term safety with no serious adverse events. 6 months after receipt of the second COVAXIN® dose: Durable neutralising, T and B cell responses detected, which suggests good immune memory responses and…